BIONORDIKA DENMARK A/S: Financial statements 2025
CVR: 17150774
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIONORDIKA DENMARK A/S (CVR 17150774) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 14,623,391 and a net result of DKK 4,736,523 compared with DKK 6,279,422 the year before. That is a decrease of 9.9% compared with the year before. Equity in the 2025 report amounted to DKK 23,840,415. The solvency ratio was 75.8%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 14,623,391
- Profit/Loss
- DKK 4,736,523
- Equity
- DKK 23,840,415
- Total Assets
- DKK 31,448,612
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 14.6M | 4.7M | 23.8M | 11 |
| 2024 | - | 16.2M | 6.3M | 25.6M | 11 |
| 2023 | - | 13.9M | 6.3M | 29.3M | 11 |
| 2022 | - | 54.8M | 36.4M | 59.1M | 11 |
| 2021 | - | 92.5M | 65M | 87.7M | 11 |
Official annual report
How creditworthy is BIONORDIKA DENMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 7, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of BIONORDIKA DENMARK A/S.
As of August 7, 2025, KPMG P/S has stepped down as auditor of BIONORDIKA DENMARK A/S.
As of August 7, 2025, Jussi Sakari Kurittu has joined the board of directors of BIONORDIKA DENMARK A/S.
As of August 7, 2025, Rolf Mattias Bengtsson has left the board of directors of BIONORDIKA DENMARK A/S.
BIONORDIKA DENMARK A/S has published its annual report for 2024. Gross profit came to DKK 16,231,945, and the net result was DKK 6,279,422.
About BIONORDIKA DENMARK A/S
BIONORDIKA DENMARK A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1993. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named MEDINOVA SCIENTIFIC A/S and ApS KBUS 38 NR. 2890. The management consists of Kirsten Skovmøller Lysemose. The board consists of Jussi Sakari Kurittu (chair), Haakon Rivertz Torgersen, Kirsten Skovmøller Lysemose and Michael Hartmann. The company is owned by BioNordika Holding AB. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 14,623,391 and a net result of DKK 4,736,523 compared with DKK 6,279,422 the year before. Equity in the 2025 report amounted to DKK 23,840,415.
